Muqing Yu

2.8k total citations · 1 hit paper
11 papers, 1.7k citations indexed

About

Muqing Yu is a scholar working on Infectious Diseases, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Muqing Yu has authored 11 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Neurology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Muqing Yu's work include COVID-19 Clinical Research Studies (4 papers), Long-Term Effects of COVID-19 (4 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (2 papers). Muqing Yu is often cited by papers focused on COVID-19 Clinical Research Studies (4 papers), Long-Term Effects of COVID-19 (4 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (2 papers). Muqing Yu collaborates with scholars based in China and Germany. Muqing Yu's co-authors include Xiansheng Liu, Shuyun Xu, Min Zhou, Xiaochen Li, Ke Wang, Min Xie, Bo Wu, Jing Shi, Ying Zhou and Zhenyu Yang and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Frontiers in Immunology and Medicine.

In The Last Decade

Muqing Yu

11 papers receiving 1.7k citations

Hit Papers

Risk factors for severity and mortality in adult COVID-19... 2020 2026 2022 2024 2020 500 1000 1.5k

Peers

Muqing Yu
Luke O’Donnell United Kingdom
Jiahao Peng United States
Buyun Xu China
Muqing Yu
Citations per year, relative to Muqing Yu Muqing Yu (= 1×) peers Junqing Yue

Countries citing papers authored by Muqing Yu

Since Specialization
Citations

This map shows the geographic impact of Muqing Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muqing Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muqing Yu more than expected).

Fields of papers citing papers by Muqing Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muqing Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muqing Yu. The network helps show where Muqing Yu may publish in the future.

Co-authorship network of co-authors of Muqing Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Muqing Yu. A scholar is included among the top collaborators of Muqing Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muqing Yu. Muqing Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Yu, Muqing, et al.. (2023). Tuberculosis combined with Burkitt lymphoma in a kidney transplant recipient: A case report and literature review. Medicine. 102(18). e33671–e33671. 1 indexed citations
2.
Yu, Muqing, et al.. (2021). Respiratory supports of COVID-19 patients in intensive care unit: A systematic review. Heliyon. 7(4). e06813–e06813. 10 indexed citations
3.
Gong, Jie, et al.. (2021). Pre-existing interstitial lung disease in patients with coronavirus disease 2019: A meta-analysis. International Immunopharmacology. 100. 108145–108145. 14 indexed citations
4.
Cheng, Xue, Wei Wang, Lang Jiang, et al.. (2021). Activation and Functional Alteration of Mucosal-Associated Invariant T Cells in Adult Patients With Community-Acquired Pneumonia. Frontiers in Immunology. 12. 788406–788406. 5 indexed citations
5.
Li, Xiaochen, Shuyun Xu, Muqing Yu, et al.. (2020). Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. Journal of Allergy and Clinical Immunology. 146(1). 110–118. 1537 indexed citations breakdown →
6.
Zhang, Nan, Cheng Wang, Feng Zhu, et al.. (2020). Risk Factors for Poor Outcomes of Diabetes Patients With COVID-19: A Single-Center, Retrospective Study in Early Outbreak in China. Frontiers in Endocrinology. 11. 571037–571037. 29 indexed citations
7.
Lu, Qin, Xiaochen Li, Jing Shi, et al.. (2020). Gendered effects on inflammation reaction and outcome of COVID‐19 patients in Wuhan. Journal of Medical Virology. 92(11). 2684–2692. 73 indexed citations
8.
Yu, Muqing, et al.. (2017). Small interfering RNA against ERK1/2 attenuates cigarette smoke‑induced pulmonary vascular remodeling. Experimental and Therapeutic Medicine. 14(5). 4671–4680. 6 indexed citations
9.
Yu, Muqing, Xiansheng Liu, Jianmiao Wang, & Yongjian Xu. (2013). CD8+ Tc-lymphocytes immunodeviation in peripheral blood and airway from patients of chronic obstructive pulmonary disease and changes after short-term smoking cessation. Chinese Medical Journal. 126(19). 3608–3615. 12 indexed citations
10.
Yu, Muqing, et al.. (2013). ERK1/2 Promotes cigarette smoke-induced rat pulmonary artery smooth muscle cells proliferation and pulmonary vascular remodeling via up-regulating cycline1 expression. Journal of Huazhong University of Science and Technology [Medical Sciences]. 33(3). 315–322. 8 indexed citations
11.
Liu, Kui, Xiansheng Liu, Muqing Yu, & Yongjian Xu. (2013). Change of extracellular signal-regulated kinase expression in pulmonary arteries from smokers with and without chronic obstructive pulmonary disease. Experimental Lung Research. 39(4-5). 162–172. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026